|
PHRF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.204600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.129400E-01 |
| Normal-vs-Stage2 |
1.136750E-01 |
| Normal-vs-Stage3 |
6.616200E-01 |
| Normal-vs-Stage4 |
2.860700E-03 |
| Stage1-vs-Stage2 |
4.815800E-01 |
| Stage1-vs-Stage3 |
1.654810E-01 |
| Stage1-vs-Stage4 |
4.784400E-02 |
| Stage2-vs-Stage3 |
1.186580E-01 |
| Stage2-vs-Stage4 |
1.716190E-01 |
| Stage3-vs-Stage4 |
1.505670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.874600E-01 |
| Normal-vs-AfricanAmerican |
2.909600E-01 |
| Normal-vs-Asian |
6.501600E-01 |
| Caucasian-vs-AfricanAmerican |
8.415400E-01 |
| Caucasian-vs-Asian |
9.870800E-01 |
| AfricanAmerican-vs-Asian |
9.269800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.660640E-01 |
| Normal-vs-Female |
8.372600E-01 |
| Male-vs-Female |
9.222300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.718400E-01 |
| Normal-vs-Extreme_Weight |
1.271560E-01 |
| Normal-vs-Obese |
5.622800E-01 |
| Normal-vs-Extreme_Obese |
1.243600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.956400E-01 |
| Normal_Weight-vs-Obese |
9.334000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.422400E-01 |
| Extreme_Weight-vs-Obese |
3.684200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.278800E-01 |
| Obese-vs-Extreme_Obese |
4.081000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.116300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.431600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.922300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.497920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.298010E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.758910E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.559800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.621900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.096000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.093200E-01 |
| Normal-VS-Type2 PRCC |
8.301900E-03 |
| Normal-VS-KIRP CIMP |
5.830800E-01 |
| Normal-VS-Unclassified PRCC |
5.916800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.250050E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.861600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.616400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.361000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.975500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.864200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.220000E-02 |
| Normal-vs-N1 |
6.221800E-01 |
| Normal-vs-N2 |
7.403700E-02 |
| N0-vs-N1 |
2.013800E-01 |
| N0-vs-N2 |
5.519200E-01 |
| N1-vs-N2 |
3.232600E-01 |
|
|
